XORTX Therapeutics (XRTX) Common Equity (2020 - 2026)
XORTX Therapeutics (XRTX) reported Common Equity of $5.5 million for the quarter ended Jun 30, 2026, up 171.1% from $2.03 million a year earlier and up 328.8% from the prior quarter.
Powered by 
Analysis
XORTX Therapeutics (XRTX) Common Equity (2020 - 2026) Analysis & Trends
As of Dec 31, 2025, XORTX Therapeutics posted Common Equity of $2.08 million, down 37.5% from the prior year.
- Common Equity has declined for four consecutive years, though with a five-year compound annual growth rate of 16.1% (years ended Dec 2020 to Dec 2025).
- By year, Common Equity came in at $3.34 million in the year ended Dec 31, 2024 (-28.1%), $4.64 million in the year ended Dec 31, 2023 (-33.7%), $7 million in the year ended Dec 31, 2022 (-47.0%) and $13.2 million in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly Common Equity since the quarter ended Sep 30, 2023.
- Year over year, Common Equity gained in two of the last eight quarters, with an average decline of 4.4%.
- The high point for year-over-year Common Equity in five years was the quarter ended Jun 30, 2026 (growth of 171.1%); the low point was the quarter ended Mar 31, 2024 (a decline of 72.5%).
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $1.28 million (quarter ended Mar 31, 2026), $2.08 million (quarter ended Dec 31, 2025) and $1.97 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | XORTX Therapeutics | 1.62 Mn | -1.68 Mn | - | 5.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.50 Mn |
| Mar 31, 2026 | 1.28 Mn |
| Dec 31, 2025 | 2.08 Mn |
| Sep 30, 2025 | 1.97 Mn |
| Jun 30, 2025 | 2.03 Mn |
| Mar 31, 2025 | 2.74 Mn |
| Dec 31, 2024 | 3.34 Mn |
| Sep 30, 2024 | 2.13 Mn |
| Jun 30, 2024 | 2.70 Mn |
| Mar 31, 2024 | 2.49 Mn |
| Dec 31, 2023 | 4.64 Mn |
| Sep 30, 2023 | 6.09 Mn |
| Jun 30, 2023 | 7.40 Mn |
| Mar 31, 2023 | 9.06 Mn |
| Dec 31, 2022 | 6.97 Mn |
| Sep 30, 2022 | 8.21 Mn |
| Jun 30, 2022 | 9.60 Mn |
| Mar 31, 2022 | 10.58 Mn |
| Dec 31, 2021 | 13.28 Mn |
| Sep 30, 2021 | 10.37 Mn |
API Access
XORTX Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=XRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "XRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=XRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();